Towards the “Africa We Want”: Looking Ahead to G20 Priorities on Health for Africa: Manufacturing

The 20th Heads of State and Government Summit of the Group of 20 (G20) in 2025 promises to be an extraordinary event, marking Africa’s inaugural hosting of the G20 Summit on its own soil, in South Africa.

This historic occasion not only symbolizes Africa’s growing influence on the global stage but also underscores the critical role of the Global South Troikaship, championed by India, Brazil, and South Africa, in addressing the unique perspectives and challenges faced by developing nations.

One of the focal points of the upcoming G20 Summit will be the culmination of efforts to bolster local and regional manufacturing capabilities, particularly in the realm of vaccines, therapeutics, and diagnostics (VTDs). Building on previous commitments outlined in the Bali and New Delhi Declarations, G20 members are poised to accelerate the timeline for VTD manufacturing and distribution, aiming to reduce it from 300 to 100 days while ensuring equitable access and affordability.

Against this backdrop, Amref Health Africa and PATH host a side-event at the 77th World Health Assembly to provide a pivotal platform for AU Member States to strategize on enhancing health research and development (R&D), pooled procurement, and manufacturing in the Global South. With a focus on sustainable localized manufacturing in Low- and Middle-Income Countries (LMICs), this event aims to broaden consensus, understand the role of the AU Commission, and shape priorities for manufacturing during Brazil and South Africa’s respective G20 presidencies.

By fostering dialogue, driving actionable recommendations, and leveraging strategic partnerships, this gathering holds the promise of advancing Africa’s manufacturing agenda, ensuring equitable access to life-saving medical technologies, and strengthening global health security for generations to come.